$10.13
-0.27 (-2.60%)
Open$10.27
Previous Close$10.40
Day High$10.45
Day Low$9.90
52W High$55.89
52W Low$5.20
Volume—
Avg Volume291.9K
Market Cap157.35M
P/E Ratio—
EPS$-12.47
SectorBiotechnology
Analyst Ratings
Buy
16 analysts
Price Target
-60.1% upside
Current
$10.13
$10.13
Target
$4.04
$4.04
$2.50
$4.04 avg
$4.74
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.80M | 12.75M | 16.40M |
| Net Income | -179,837,502 | -210,527,772 | -3,544,265 |
| Profit Margin | -1,834.5% | -1,742.8% | -21.6% |
| EBITDA | -172,295,641 | -212,904,343 | -3,398,004 |
| Free Cash Flow | — | — | -3,167,900 |
| Rev Growth | -23.1% | -23.1% | +19.8% |
| Debt/Equity | — | — | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |